- Home
- AVTX vs PGC Comparison
AVTX vs PGC Comparison
Compare AVTX & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVTX | PGC |
|---|---|---|
| Founded | 2011 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 710.1M | 769.6M |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AVTX | PGC |
|---|---|---|
| Price | $7.48 | $45.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 4 |
| Target Price | $44.08 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 1.0M | 94.9K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.46% |
| EPS Growth | ★ 72.07 | 13.51 |
| EPS | N/A | ★ 1.65 |
| Revenue | $27,813,137.00 | ★ $282,995,000.00 |
| Revenue This Year | N/A | $24.36 |
| Revenue Next Year | N/A | $12.76 |
| P/E Ratio | ★ N/A | $26.64 |
| Revenue Growth | ★ 2312.27 | 24.05 |
| 52 Week Low | $11.21 | $24.71 |
| 52 Week High | $24.27 | $49.14 |
Technical Indicators
Market Signals| Indicator | AVTX | PGC |
|---|---|---|
| Relative Strength Index (RSI) | 18.40 | 58.51 |
| Support Level | N/A | $44.32 |
| Resistance Level | $20.54 | $45.22 |
| Average True Range (ATR) | 0.97 | 0.86 |
| MACD | -0.26 | 0.17 |
| Stochastic Oscillator | 8.65 | 95.09 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp is a bank holding company. Through its subsidiaries, the company offers various wealth management, investment banking, and commercial and personal banking solutions to its clients. The company has two reportable segments: Banking, which generates the maximum revenue, and Wealth Management. The Banking segment includes commercial, commercial real estate, multifamily, residential, and consumer lending activities; treasury management services; escrow management; deposit generation; operation of ATMs; telephone and internet banking services; credit card services, etc. The Wealth Management segment offers investment management services for individuals and institutions; personal trust services; and other financial planning and advisory services.